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Abstract
The additive sorbitan monolaurate consists of sorbitol (and its anhydrides) esteriﬁed with fatty acids
derived from coconut oil. It is intended to be used as a technological additive, functional group:
emulsiﬁer, in feedingstuffs for all animal species, at a maximum concentration of 85 mg/kg complete
feed. The EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
concluded that sorbitan monolaurate is safe for all animal species at the proposed maximum content
of 85 mg/kg complete feed and that the use of sorbitan monolaurate in animal nutrition is not
expected to pose a risk for the consumer under the proposed conditions of use. Users are unlikely to
be exposed to sorbitan monolaurate via inhalation. Sorbitan monolaurate is irritant to skin and eyes
and it is not considered a skin sensitiser. Owing the lack of data, the FEEDAP Panel cannot conclude on
the safety of the additive for the environment. Sorbitan monolaurate is authorised for use as a food
additive with the function of emulsiﬁer. The technological effect underlying its use as a food additive
could reasonably be expected to be seen when used in feed.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 10(2) of that Regulation also speciﬁes that for
existing products within the meaning of Article 10(1), an application shall be submitted in accordance
with Article 7, at the latest one year before the expiry date of the authorisation given pursuant to
Directive 70/524/EEC for additives with a limited authorisation period, and within a maximum of seven
years after the entry into force of this Regulation for additives authorised without a time limit or
pursuant to Directive 82/471/EEC.
The European Commission received a request from Kemin Europa N.V.2 for re-evaluation of the
authorisation of the product sorbitan monolaurate, when used as a feed additive for all animal species
(category: technological additive; functional group: emulsiﬁers).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 10(2) (re-
evaluation of an authorised feed additive). The particulars and documents in support of the application
were considered valid by EFSA as of 24 April 2014.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product sorbitan monolaurate, when used under the proposed conditions of use (see Section 3.1.3).
1.2. Additional information
Sorbitan monolaurate is currently authorised as a technological additive, functional group (c)
emulsiﬁer, for all animal.
Sorbitan monolaurate (E 493) is approved as a food additive (COMMISSION REGULATION (EU)
No 1129/2011)3 in a wide range of commonly consumed foods (up to 10 g/kg), including dietary food
supplements (quantum satis).
The additive has been assessed by the Scientiﬁc Committee on Food (SCF), which established a
group acceptable daily intake (ADI) of 5 mg/kg body weight (bw) per day for sorbitan monolaurate
and sorbitan monooleate (European Commission (1978). The Joint Food and Agriculture Organization
of the United Nations (FAO)/World Health Organization (WHO) Expert Committee on Food Additives
also assessed the additive (WHO, 1982). The Committee included sorbitan monolaurate in the group
ADI of 25 mg/kg bw per day already set for the other sorbitan esters.
The EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) (EFSA ANS Panel,
2017) assessed the sorbitan esters sorbitan monostearate (E 491), sorbitan tristearate (E 492),
sorbitan monolaurate (E 493), sorbitan monooleate (E 494) and sorbitan monopalmitate (E 495). The
ANS Panel established a group ADI of 10 mg/kg bw per day, expressed as sorbitan, for sorbitan esters
(E 491, E 492, E 493, E 494 and E 495) singly or in combination.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier4 in support of the authorisation request for the use of sorbitan monolaurate as a feed additive.
The FEEDAP Panel used the data provided by the applicant together with data from other sources,
such as previous risk assessments by EFSA or other expert bodies and peer-reviewed scientiﬁc papers
to deliver the present output.
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Kemin Europa N.V. Toekomstlaan 42, 2200, Herentals Belgium.
3 Commission Regulation (EU) No 1129/2011 of 11 November 2011 amending Annex II to Regulation (EC) No 1333/2008 of the
European Parliament and of the Council by establishing a Union list of food additives. OJ L 295, 12.11.2011, p. 1–177.
4 FEED dossier reference: FAD-2010-0333.
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EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the sorbitan monolaurate in animal feed. The Executive Summary of
the EURL report can be found in Annex A.5
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of sorbitan
monolaurate is in line with the principles laid down in Regulation (EC) No 429/20086 and the relevant
guidance documents:
Guidance on technological additives (EFSA FEEDAP Panel, 2012a), Technical guidance: Tolerance
and efﬁcacy studies in target animals (EFSA FEEDAP Panel, 2011), Technical Guidance for assessing
the safety of feed additives for the environment (EFSA, 2008a), Guidance for the preparation of
dossiers for the re-evaluation of certain additives already authorised under Directive 70/524/EEC
(EFSA, 2008b), Guidance for the preparation of dossiers for additives already authorised for use in
food (EFSA FEEDAP Panel, 2012b), Guidance for establishing the safety of additives for the consumer
(EFSA FEEDAP Panel, 2012c) and Guidance on studies concerning the safety of use of the additive for
users/workers (EFSA FEEDAP Panel, 2012d).
3. Assessment
The additive under assessment, sorbitan monolaurate, is intended to be used as a technological
additive (functional group: emulsiﬁers) in feedingstuffs for all animal species.
3.1. Characterisation
3.1.1. Characterisation of additive
The additive sorbitan monolaurate consists of sorbitol (and its anhydrides) with fatty acids
derived from coconut oil.
The additive
is a yellow/amber oily liquid, it is insoluble in water.
The typical fatty acid proﬁle of the additive sorbitan monolaurate reﬂects the fatty acid composition
of coconut oil and is speciﬁed to contain 40–60% lauric acid, 14–25% myristic acid, 7–15% palmitic
acid, < 11% oleic acid, < 10% caprylic acid, < 10% capric acid, < 7% stearic acid, < 3% linoleic acid
and < 1% caproic acid.
The predominant structure is sorbitan monolaurate, from which the additive derives its name
(synonyms: sorbitan laurate, sorbitan monododecanoate; Chemical Abstract Service (CAS) number
1338-39-2 and EINECS number 215-663-3; molecular weight 346.46, density about 1,030 kg/m3). The
structural formula of sorbitan monolaurate is described in Figure 1.
5 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/files/FinRep-FAD-2010-0333%20Sorbitan%
20monolaurate.pdf
6 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
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The additive is manufactured to meet the speciﬁcations set by Commission Regulation (EU)
No 231/20127 for use as a food additive. The additive is speciﬁed to contain not less than 95% of a
mixture of sorbitol, sorbitan and isosorbide esters. The analysis of ﬁve batches of the additive8 showed
compliance with the above speciﬁcations. The additive is further speciﬁed to contain ≤ 2% water and
≤ 0.5% sulfated ash, and to have acid value ≤ 7,9 saponiﬁcation value between ≥ 155 and ≤ 170,10
and hydroxyl value between ≥ 330 and ≤ 358.11 The analysis of ﬁve batches8 showed that also these
speciﬁcations were met in all samples. The applicant proposed two additional speciﬁcations for
sorbitan monolaurate as a feed additive: iodine value ≤ 1012 and peroxide value ≤ 5.13 The analysis of
the same ﬁve batches showed compliance also with these speciﬁcations.
3.1.2. Purity
The analysed concentrations of lead (≤ 5 mg/kg), cadmium (≤ 1 mg/kg), mercury (≤ 1 mg/kg) and
arsenic (≤ 3 mg/kg) in ﬁve batches of the additive8 were below the proposed speciﬁcations (≤ 5, ≤ 1,
≤ 1 and ≤ 3 mg/kg, respectively). None of them raises a safety concern.
3.1.3. Stability and homogeneity
The shelf life of the additive was studied by analysing the water content, the acid value, the
saponiﬁcation value and the hydroxyl value of three production batches stored in sealed containers at
room temperature for 24 months.15 Essentially no changes in the analysed parameters were observed
over the storage period.
No speciﬁc studies for the stability in feedingstuffs were submitted. For technological additives,
stability in feedingstuffs can be demonstrated by persistence of the effect, and no demonstration of
homogeneous distribution is considered necessary if the efﬁcacy of the additive as emulsiﬁer is
demonstrated. Sorbitan monolaurate is authorised as a food additive, and the emulsifying effect seen
when used in food could reasonably be expected to be seen when used in feed.
Figure 1: Structural formula of sorbitan monolaurate
7 Commission Regulation (EU) No 231/2012 of 9 March 2012 laying down speciﬁcations for food additives listed in Annexes II
and III to Regulation (EC) No 1333/2008 of the European Parliament and of the Council. OJ No L 83, 22.3.2012, p. 1.
8 Supplementary Information August 2015/Annex_1.
9 Milligrams of potassium hydroxide required to neutralize the free acids in one gram of the material.
10 Milligrams of potassium hydroxide required to saponify all fatty acids contained in one gram of the material.
11 Milligrams of potassium hydroxide necessary to neutralise the acetic acid which combines on acetylation of one gram of
sample.
12 Grams of iodine is consumed by 100 grams of fat.
13 Grams of peroxide oxygen in one kg of fat; is determined by measuring the amount of iodine which is formed by the reaction
of peroxides with iodide ion.
15 Technical dossier/Section II/Annex_II_3.
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3.1.4. Conditions of use
The additive is intended to be used as a emulsiﬁer in feed materials and compound feed quantum
satis but with a maximum content of 85 mg sorbitan monolaurate/kg complete feed.
3.2. Safety
3.2.1. Absorption, distribution, metabolism and excretion (ADME) and residues
No speciﬁc data were submitted by the applicant concerning the ADME and residues of sorbitan
monolaurate in the target species. However, information is available concerning the metabolic fate of
the homologous compounds sorbitan monostearate and sorbitan trioleate.
3.2.1.1. ADME
In its assessment of sorbitan-fatty acid esters the ANS Panel (EFSA ANS Panel, 2017) noted that
‘there were indications from toxicokinetic studies in rats with radiolabelled sorbitan monostearate that
this sorbitan ester can be either hydrolysed to its fatty acid moiety and the corresponding anhydrides
of sorbitol or excreted intact in the faeces. After absorption, as indicated by radioactivity, sorbitan and
isosorbide moieties, sorbitol or metabolites thereof were excreted via urine or exhaled as CO2. The
fatty acid moiety entered the endogenous metabolism of fatty acids. The Panel considered that in case
intact sorbitan monostearate be absorbed it would be hydrolysed pre-systemically’. The
Panel considered that these results would qualitatively apply to the homologous fatty esters of
sorbitan.
The pancreas is generally assumed to be the major source of digestive lipase enzymes in ﬁsh as it
is in mammals (Tocher, 2003). The same has been shown to occur in birds (Krogdahl, 1985).
Consequently, the sorbitan moiety of sorbitan monolaurate is likely to be released in the digestive tract
of these species and undergo a similar metabolic fate as in the rat.
3.2.1.2. Residues
One group of nine rats were fed for 28 days a diet containing 0.1% sorbitan monostearate 14C-
labelled in the polyol moiety. Animals were sacriﬁced and the carcasses were frozen and lyophilised.
Aliquots were extracted with hot chloroform and the solid extract was saponiﬁed; fatty acids were
solvent extracted; the remaining phase contained the water-soluble hydrolytic products of the crude
fat, including glycerol and any deposited anhydrosorbitol polyols. The analysis of the radioactivity of
the different fractions indicated that 0.35% of the administered radioactivity was incorporated in the
crude fat, 0.23% in the fatty acids, 0.03% in glycerol and 0.04% in unidentiﬁed residues comprising
anhydrosorbitol polyols (Wick and Joseph, 1953). These results indicate that the sorbitan moiety is
metabolised to a very low extent and is not expected to accumulate in the whole animal. It is
reasonable to assume that no accumulation would occur in ﬁsh and bird edible tissues either.
3.2.2. Toxicological studies
The toxicology of sorbitan monolaurate has been previously evaluated by JECFA (WHO, 1974,
1982), the SCF (European Commission, 1978) and more recently by EFSA ANS Panel (EFSA, 2017) in
relation to its use as a food additive. In 1978, the SCF established a group ADI for sorbitan
monolaurate (E 493) and sorbitan monooleate (E 494), singly or in combination, of 5 mg/kg bw per
day, calculated as sorbitan monolaurate. In 1982, based on long-term (2 years) studies in rats (WHO,
1982), a no observed adverse effect level (NOAEL) of 50,000 mg/kg diet (5%) was identiﬁed and
considered equivalent to 2,500 mg/kg bw. By applying a safety factor of 100, a group ADI of
0–25 mg/kg bw for sorbitan esters was established.
The ANS Panel (EFSA, 2017) re-evaluated sorbitan monolaurate as a food additive together with
other sorbitan esters (i.e. mono- and tristearate, monopalmitate and monooleate). In this opinion, two
in vitro genotoxicity studies were described both made with sorbitan monolaurate: an in vitro
chromosomal aberrations assay in cultured peripheral human lymphocytes and an in vitro mammalian
cell gene mutation assay in L5178Y (Tk+/) mouse lymphoma cells. Both these studies were
performed according to Good Laboratory Practice (GLP) and following the relevant OECD Guidelines
and were considered sufﬁcient to exclude the genotoxicity of the substance. Furthermore, no relevant
structural alert for both in vitro and in vivo genotoxicity were found for any of the sorbitan esters
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when assessed by the OECD QSAR Toolbox. The FEEDAP Panel concludes that sorbitan monolaurate
do not raise concern with respect to genotoxicity.
After reviewing the toxicity studies mentioned in the WHO evaluation performed in rats, monkeys
and hamsters, the ANS Panel derived a NOAEL of 2,100 mg sorbitan monolaurate/kg bw per day and
2,300 mg sorbitan monolaurate/kg bw per day for males and females, respectively. The NOAEL was
derived from a study in which Wistar rats (15 males and 15 females) were fed sorbitan monolaurate at
dietary levels of 0, 2.5, 5.0 and 10% for 90 days corresponding to 0, 2,100, 4,200 and 8,000 mg
sorbitan monolaurate/kg bw per day for males, and 0, 2,300, 4,500 and 8,400 mg sorbitan
monolaurate/kg bw per day for females. However, no suitable long-term studies with sorbitan
monolaurate could be identiﬁed.
Based on kidney lesions, the ANS identiﬁed a NOAEL of 2% for sodium monostearate
(corresponding to 2,600 mg/kg bw per day) in male mice exposed to 0%, 0.5%, 2% or 4% of the
additive for 80 weeks (Hendy et al., 1978). In that study, no increase in tumour incidences was found.
The ANS Panel also considered that ‘the available reproductive and developmental toxicity studies with
sorbitan monostearate have limitations but no adverse effects were reported’.
The ANS Panel noted that (i) similar kinetics is expected for all the considered sorbitan esters, (ii) it
is presumable that the kidney adverse effects used to derive the NOAEL for sodium monostearate are
due to the sorbitan moiety, which is shared by all the esters under evaluation and (iii) the metabolic
fate of all fatty acids deriving from ester hydrolysis is expected to be the same irrespective of the
number of their carbon atoms.
According to these assumptions, the ANS Panel adopted a read-across approach and concluded
that there was no need to set a separate ADI for sorbitan monolaurate and the other considered
esters. Based on the long-term mice study on sorbitan monostearate (Hendy et al., 1978), the ANS
Panel established a group ADI of 10 mg sorbitan/kg bw per day for sorbitan monolaurate and all the
examined esters, singly or in combination, taking into account the ratio between the molecular weight
of sorbitan monostearate (430.62) and of sorbitan (164.16) and applying a safety factor of 100.
The FEEDAP Panel follows the approach of the EFSA ANS Panel (2017) with its proposed group ADI
of 10 mg sorbitan/kg bw per day for all sorbitan monoesters, singly or in combination. When applied
to sorbitan monolaurate, this would correspond (based on its molecular weight) to an ADI of 21 mg
sorbitan monolaurate/kg bw per day.
3.2.3. Safety for the target species
To support the safety of sorbitan monolaurate for all animal species, the applicant has performed
three tolerance studies, one with chickens for fattening, one with dairy cows and one with weaned
piglets.
3.2.3.1. Safety for chickens for fattening
A total of 756 one-day-old male chickens (Ross 308) was fed diets supplemented with 0, 85 (19
the maximum recommended dose) or 8,500 (1009 the maximum recommended dose) mg sorbitan
monolaurate/kg feed.16 Group size was twelve replicates with 21 birds each. The diets (starter, from
day 1 to day 14; grower, from day 15 to day 28; ﬁnisher, from day 29 to day 35), consisting mainly of
maize, wheat and soybean meal, were isonitrogenous (starter: 22.0% crude protein (CP); grower:
20.5% CP; ﬁnisher: 19.5% CP). The concentration of the additive was analytically conﬁrmed. Feeds
(mash form) and water were offered ad libitum for 35 days. Health status and mortality were
monitored daily and most probable cause of death determined by necropsy. Feed intake (pen) and
body weight (individual) were recorded at the beginning, and days 7, 14, 21, 28 and 35 of the
experiment and average daily body weight gain and feed to gain ratio were calculated. At the end of
the experiment, a blood sample was taken from two chickens per pen (randomly selected) for routine
blood haematology17 and biochemistry.18 An analysis of variance (ANOVA) was performed with the
data considering the pen for zootechnical parameters or the bird (blood analysis) as the experimental
unit and group means were compared by Tukey’s test. Signiﬁcance level was set at p < 0.05.
16 Technical dossier/Supplementary information October 2017/Section III/Annex III 1.
17 Red blood cell count (RBC), haematocrit, haemoglobin, white blood cell count (WBC), white blood cell differentials (segmented
neutrophils, lymphocytes, monocytes, eosinophils, basophils, erythroblasts).
18 Total protein, urea, cholesterol, alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-
glutamyltranspeptidase (GGT), bilirubin, albumin, globulin, calcium, phosphate inorg.
Sorbitan monolaurate for all animal species
www.efsa.europa.eu/efsajournal 8 EFSA Journal 2019;17(3):5651
Mortality and culling of birds were low in each treatment (in total < 4%). Performance parameters
were not affected by treatments and mean values were for daily feed intake 94.5 g/day, for ﬁnal body
weight 2.28 kg, for body weight gain 63.8 g/day and for feed to gain ratio 1.47. No treatment effects
were observed either in the haematological and biochemical parameters. The sorbitan monolaurate
supplementation up to 100-fold the recommended dose of 85 mg/kg feed did not adversely affect the
health and performance of the chickens.
3.2.3.2. Safety for dairy cows
A total of 60 Holstein primi- and multiparous cows was fed total mixed ration (TMR) mainly
composed of maize silage, wheat silage, ryegrass hay, fescue hay, alfalfa hay, maize, barley, and
soybean meal supplemented with 0, 85 (19 the maximum recommended dose) or 850 (109 the
maximum recommended dose) mg sorbitan monolaurate/kg of complete feed (88% dry matter).19
Group size was 20 cows which were housed in one pen, but fed individually to speciﬁc bins under an
electronic feed monitoring system. The diets were calculated to be isonitrogenous (16.2% CP) and
isocaloric (about 6.82 MJ net energy for lactation (NEL)/kg). The concentration of the additive was
analytically conﬁrmed. TMR and water were offered ad libitum for 56 days. Health status and mortality
were monitored daily. Individual feed intake, body weight, milk production and milk composition were
recorded daily. Milk samples were collected from each cow once a week to determine somatic cell
counts. At the end of the experiment, a blood sample was taken from all animals per treatment for
haematology20 and clinical biochemistry.21 Data for performance parameters were analysed with a
mixed model considering the ﬁxed effects of treatment, time of sampling, parity and their three-way
interactions, plus the random effect of cow with days in milk as a covariate, with the animal as
experimental unit. Data for blood parameters were analysed with one-way ANOVA considering the
ﬁxed effect of treatment, with the animal as the experimental unit. Signiﬁcance level was set at
p < 0.05.
No mortality occurred. Mean values were for daily feed intake 23.0 kg dry matter/day and for milk
yield 38.4 kg/day. No negative effects were observed in any measured performance parameter in the
groups receiving sorbitan monolaurate compared to the control group. Among the haematological
parameters, the percentage of basophils was signiﬁcantly higher in the recommended dose group,
compared to the control, but not in the overdose group. Chlorine and sodium concentrations were
signiﬁcantly lower in the overdose group, compared to the control. Although the difference observed
were signiﬁcant, the changes were small and are not considered of toxicological concern. No other
treatment-related effects were observed in the haematological or in the biochemical parameters. The
sorbitan monolaurate supplementation up to 10-fold the recommended dose of 85 mg/kg feed did not
adversely affect the health and performance of dairy cows.
3.2.3.3. Safety for weaned piglets
A total of 72 castrated male and 72 female piglets (DanBred 9 Goland, 34 days of age, body
weight 7.7 kg) was fed diets supplemented with 0, 85 (19 the maximum recommended dose) or 8,500
(1009 the maximum recommended dose) mg sorbitan monolaurate/kg feed.22 Group size was 12
replicates with four pigs each (representing six pens with castrated males and six pens with females
per treatment). The diets (prestarter, from day 1 to day 14; starter, from day 15 to day 42), consisting
mainly of barley, wheat, maize, and soybean meal, were isonitrogenous (prestarter: 17.4% CP; starter:
17.1% CP) and isocaloric (prestarter: 10.6 MJ net energy (NE)/kg; starter: 10.5 MJ NE/kg). The
concentration of the additive was analytically conﬁrmed. Feeds (mash form) and water were offered
ad libitum for 42 days. Health status and mortality were monitored daily and most probable cause of
19 Technical dossier/Supplementary information October 2017/Section III/Annex III 2.
20 Red blood cell count (RBC), haemoglobin (Hb), packed cell volume (PCV), reticulocytes, mean corpuscular volume (MCV),
mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), platelets, mean platelet volume
(MPV), white blood cell count (WBC), white blood cell differentials (neutrophils, lymphocytes, monocytes, eosinophils,
basophils).
21 Alkaline phosphatase, amylase, gamma-glutamyltranspeptidase (GGT), alanine aminotransferase (ALT), aspartate
aminotransferase (AST), lactate dehydrogenase (LDH), creatine phosphokinase (CPK), calcium, phosphorous, magnesium,
potassium, sodium, chlorine, cholesterol, lactic acid, albumin, total protein, urea, creatinine, non-esteriﬁed fatty acids (NEFA),
glucose and total bilirubin.
22 Technical dossier/Supplementary information October 2017/Section III/Annex III 3.
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death determined by necropsy. Feed intake and body weight were recorded at the beginning, and
days 7, 14, 21, 28, 35 and 42 of the experiment and average daily body weight gain and feed to gain
ratio were calculated. At the end of the experiment, a blood sample was taken from two piglets per
pen (representing twelve castrated males and twelve females per treatment) for routine blood
haematology23 and biochemistry.24 An ANOVA was performed with the data considering the pen or the
piglet (blood analysis) as the experimental unit and group means were compared by Tukey’s test
(performance) or Dunnett’s test (blood analysis). Signiﬁcance level was set at p < 0.05.
No mortality occurred. Performance parameters were not affected by treatments and mean values
were for daily feed intake 768.5 g/day, for ﬁnal body weight 28.1 kg, for body weight gain 484.9 g/day
and for feed to gain ratio 1.59. The number of white blood cells was signiﬁcantly higher in the overdose
group compared to the control. The total bilirubin concentration was lower in the overdose group and
Ca concentrations and ALT activity were lower in the use level group, compared to the control group.
Although the difference observed were signiﬁcant, the changes were small and are not considered of
toxicological concern. No other treatment-related effects were observed in the haematological or in the
biochemical parameters. The sorbitan monolaurate supplementation up to 100-fold the recommended
dose of 85 mg/kg feed did not adversely affect the health and performance of weaned piglets.
3.2.3.4. Conclusions on safety for the target species
The results of three tolerance studies showed that dairy cows tolerated a concentration of 850 mg
sorbitan monolaurate/kg feed (109 the proposed maximum content) and chickens for fattening and
weaned piglets tolerated a concentration of 8,500 mg sorbitan monolaurate/kg feed (1009 the
proposed maximum content). The FEEDAP Panel therefore concludes that sorbitan monolaurate is safe
for these animal species at the proposed maximum content of 85 mg/kg complete feed and extends
this conclusion to all animal species.
3.2.4. Safety for the consumer
Based on the NOAEL of 2,600 mg sorbitan monostearate/kg bw per day, taking into account
the ratio between the molecular weight of sorbitan monostearate (430.62 g/mol) and sorbitan
(164.16 g/mol), and applying an uncertainty factor of 100, the ANS Panel proposed a group ADI of
10 mg sorbitan/kg bw per day expressed as sorbitan for sorbitan esters (E 491–495) singly or in
combination. The FEEDAP Panel calculated that the corresponding ADI for sorbitan monolaurate would
be 21 mg/kg bw.
Due to the extensive metabolism of sorbitan monolaurate at the intestinal level, no residues of the
unchanged additive would be present in target animal tissues and products. The main intestinal
metabolite sorbitan can be absorbed, and then excreted in urine unchanged, only very limited
amounts being found in the whole body. Therefore, the administration of sorbitan monolaurate in
complete feeds is expected to generate negligible amounts of residues of sorbitan and derived
metabolites in food products of animal origin.
The consumption of tissues and products from animals administered the maximum recommended
concentration of sorbitan monolaurate proposed for complete feeds would not measurably add to the
exposure of the consumers. The FEEDAP Panel concludes that the use of sorbitan monolaurate in
animal nutrition under the proposed conditions of use would not pose a risk for the consumer.
3.2.5. Safety for the user
3.2.5.1. Inhalation toxicity
No inhalation toxicity studies were available, but as sorbitan monolaurate is an oily liquid users are
not expected to be exposed to it by inhalation during normal handling of the additive.
23 Red blood cell count (RBC), haematocrit, haemoglobin, mean corpuscular volume, mean corpuscular haemoglobin, mean
corpuscular haemoglobin concentration, platelets, white blood cell count (WBC), white blood cell differentials (neutrophils,
lymphocytes, monocytes, eosinophils, basophils).
24 Glucose, calcium, phosphorus inorg., total cholesterol, triglycerides, phospholipids, uric acid, creatinine, lactate
dehydrogenase, alkaline phosphatase, alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin.
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3.2.5.2. Skin and eyes
Sorbitan monolaurate was tested for skin and eye irritancy using New Zealand rabbits.25 Solutions
of 1%, 10%, 60% or 100% sorbitan monolaurate were applied to clipped skin for 10 days. After
3 days of treatment, 100% caused intense erythema and oedema, 10% and 60% caused less intense
erythema and oedema, and 1% caused no changes to exposed skin. After 10 days of treatment,
erythema and oedema were seen in all treated groups and the 60% and 100% treatments also caused
skin thickening. It was concluded that sorbitan monolaurate is irritant to rabbit skin. Although solutions
of 30% and 60% sorbitan monolaurate did not cause irritancy when applied to the eyes of rabbits,
considering that it was shown to be irritant to skin, it would be prudent to regard it as a potential
irritant to the eyes of exposed users.
Sorbitan monolaurate was tested at aqueous solution of 30% and 100% in a Schwartz Prophetic
Patch Test (two exposures of 72 h, seven days apart) for allergens using 30 and 50 human subjects,
respectively.26 No skin reactions were caused, indicating that none of the subjects were allergic to
sorbitan laurate.
3.2.5.3. Conclusions on safety for the user
Sorbitan monolaurate is regarded as an irritant to skin and eyes but is not considered a skin
sensitiser. It is not expected to be a risk for the users exposed via inhalation.
3.2.6. Safety for the environment
According to the Technical Guidance for assessing the safety of feed additives for the environment
(EFSA, 2008a), when performing Phase I assessment, 100% of the parent compound is considered to
enter the environment.
Phase I assessment
Exposure assessment
The active ingredient sorbitan monolaurate is not a physiological/natural substance of established
safety for the environment. Consequently, a Phase I assessment has to be conducted to determine the
predicted environmental concentrations (PECs) of the feed additive in relevant environmental
compartments.
The applicant supplied a phase I assessment for sorbitan monolaurate when used as a feed
additive for terrestrial and aquatic farm animals.
Additives for terrestrial animals
The PECs for sorbitan monolaurate in soil, groundwater and surface water were calculated (EFSA,
2008b), based on inclusion of the additive at a concentration of 85 mg/kg complete feed for all target
animals and 100% excretion.
The PECsoil ranged from 0.37 to 1.7 mg/kg soil from the use of sorbitan monolaurate in feed for
turkeys and lambs for fattening, respectively.
The PECgroundwater ranged from 1.0 to 4.6 lg/L and PECsurfacewater ranged from 0.3 to 1.5 lg/L
(both ranges for turkeys and lambs for fattening, respectively).
Additives for ﬁsh
The PECs from the use of sorbitan monolaurate in ﬁsh farmed in sea cages was calculated assuming
that 100% of the maximum dose (85 mg/kg feed) is excreted to the sediment as the parent compound.
The PECsediment is 0.18 mg/kg wet weight (ww) which exceeds the trigger value of 10 lg/kg ww.
The PECswaq from the use of sorbitan monolaurate in ﬁsh farmed in raceways, ponds, tanks and
recirculation systems was calculated assuming that 100% of the maximum dose (85 mg/kg feed) is
released to the surface water. The PECswaq ranged from 0.06 to 0.21 lg/L from use of the additive in
different ﬁsh species. The use of the additive for salmon would give a PECswaq below the trigger value
of 0.1 lg/L, whereas the use for rainbow trout, seabass/seabream and turbot would slightly exceed
the trigger value.
25 Technical dossier/Section III/Annex III.8.
26 Technical dossier/Section III/Annex III.5.
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Conclusions phase I assessment
As PECsoil exceeded the trigger value of 10 lg/kg, and PECgroundwater and PECsurfacewater all
exceeded the trigger values of 0.1 lg/L, a Phase II assessment is required for sorbitan monolaurate.
Since the PECswaq was around the trigger value no further assessment is required for this
environmental compartment.
Phase II assessment
Reﬁnement of PEC
Degradation studies indicate that sorbitan monolaurate is readily degradable (US EPA, 2010), and
with an estimated Kow of 3.15 (US EPA, 2005) is not expected to bioaccumulate. Limited data are
available on the ecotoxicity of sorbitan monolaurate. Studies in rats indicate that approximately 90% of
sorbitan monostearate is hydrolysed to its fatty acid moiety and the corresponding anhydrides of
sorbitol. Assuming similar metabolism of sorbitan monolaurate, a limited proportion of the additive will
be excreted to the environment. However, in the absence of quantitative data, it is not possible to
calculate reﬁned PEC values.
The FEEDAP Panel considers that the lack of data and the inherent uncertainties do not allow the
environmental risk assessment to be completed.
3.3. Efﬁcacy
Sorbitan monolaurate is authorised for use as a food additive with the function of emulsiﬁer. The
technological effect underlying its use as a food additive could reasonably be expected to be seen
when used in feed.
4. Conclusions
Sorbitan monolaurate is safe for all animal species at the proposed maximum content of 85 mg/kg
complete feed.
The use of sorbitan monolaurate in animal nutrition is not expected to pose a risk for the consumer
under the proposed conditions of use.
Users are unlikely to be exposed to sorbitan monolaurate via inhalation. Sorbitan monolaurate is
irritant to skin and eyes and it is not considered a skin sensitiser.
Owing the lack of data, the FEEDAP Panel cannot conclude on the safety of the additive for the
environment.
Sorbitan monolaurate is authorised for use as a food additive with the function of emulsiﬁer. The
technological effect underlying its use as a food additive could reasonably be expected to be seen
when used in feed.
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(EC) No 1831/2003 – Scientiﬁc assessment suspended. Issues: characterisation
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05/07/2016 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
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27/02/2019 Opinion adopted by the FEEDAP Panel. End of the Scientiﬁc assessment
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Abbreviations
ADI acceptable daily intake
ADME absorption, distribution, metabolism and excretion
ANS EFSA Scientiﬁc Panel on Additives and Nutrient Sources added to Food
ANOVA analysis of variance
bw body weight
CAS Chemical Abstracts Service
CP crude protein
CV coefﬁcient of variation
DM dry matter
ECHA European Chemicals Agency
EINECS European INventory of Existing Commercial chemical Substances
EURL European Union Reference Laboratory
FAO Food Agricultural Organization
FEEDAP Panel on Additives and Products or Substances used in Animal Feed
GC gas chromatography
GLP Good laboratory practice
JECFA The Joint FAO/WHO Expert Committee on Food Additives
Kow n-octanol/water partition coefﬁcient
log Kow logarithm of octanol–water partition coefﬁcient
NEL net energy for lactation
NOAEL no observed adverse effect level
NTP National Toxicology Program
OECD Organisation for Economic Co-operation and Development
PCBs polychlorinated biphenyl
PCDD/F polychlorinated dibenzodioxins/dibenzofurans
PEC predicted environmental concentration
PNEC predicted no effect concentrations
SCF Scientiﬁc Committee on Food
TEQ toxic equivalent
TMR total mixed ration
UF uncertainty factor
WHO World Health Organization
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Method(s) of
Analysis for sorbitan monolaurate
In the current application, authorisation is sought under article 10(2) for Sorbitan monolaurate
under the category/functional group 1(c) ‘technological additives’/ ‘emulsiﬁers’ according to the
classiﬁcation system of Annex I of Regulation (EC) No 1831/2003. Speciﬁcally, the authorisation is
sought for the use of the feed additive for all animal species and categories. Sorbitan monolaurate is
an yellow-to-amber oily liquid, consisting of a minimum of 95% of a mixture of partial esters of
sorbitol, sorbitan and isosorbide with edible commercial lauric acid; the later comprises mainly lauric
acid (ca. 40–60%), myristic acid (ca. 14–25%) and palmitic acid (ca. 7–15%). The Applicant states
that the speciﬁc purity criteria set in the Commission Directive 2008/84/EC for the food additive are
applicable for the feed additive. Sorbitan monolaurate is intended to be added to other feed additives
(mainly antioxidants) in order to assist their uniform distribution when added to other feed ingredients.
No recommended minimum or maximum concentration levels were proposed by the Applicant.
However, the typical maximum inclusion level is equivalent to 5 g of the feed additive/kg complete
feedingstuffs. For the characterisation of Sorbitan monolaurate in the feed additive, the Applicant
submitted the internationally recognised FAO JECFA monographs dedicated for Sorbitan monolaurate,
based on the determination of – saponiﬁcation-, - acid-, - hydroxyl- values; and – the assay of polyols
and fatty acids, as recommended by Commission Directive 2008/84/EC. Even though no performance
characteristics were provided, the EURL recommends for ofﬁcial control the methods described in the
above mentioned FAO JECFA monographs to characterise Sorbitan monolaurate in the feed additive.
For the characterisation of fatty acids in the feed additive, the gas chromatography (GC) method
described in the European Pharmacopoeia monographs (Eur. Ph. 6.0, 1040 and 20422) may be
applied. The accurate determination of Sorbitan monolaurate in premixtures and feedingstuffs is not
achievable experimentally. Therefore, the EURL is not able to evaluate nor recommend any method for
ofﬁcial control to determine Sorbitan monolaurate in premixtures and feedingstuffs. Further testing or
validation of the methods to be performed through the consortium of National Reference Laboratories
as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not considered necessary.
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